CDK inhibitors function by blocking the activity of specific CDKs, thus interfering with the cell cycle. This inhibition can lead to cell cycle arrest, primarily at the G1 phase, preventing cancer cells from replicating. The disruption of the cell cycle can induce apoptosis, or programmed cell death, in cancer cells, thereby reducing tumor growth.
